ArticleThe Journal of clinical investigation2025

Targeting kinesin family member 20A sensitizes stem-like triple-negative breast cancer cells to standard chemotherapy.

Yayoi Adachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.